Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
boston blog main
cancer
3
×
clinical trials
3
×
fda
3
×
life sciences
national blog main
boston top stories
cancer drugs
europe blog main
ipo
new york blog main
new york top stories
san francisco blog main
sanofi
takeda pharmaceutical
abbvie
agios pharmaceuticals
akouos
allergan
alnylam pharmaceuticals
amag pharmaceuticals
amunix
anirvan ghosh
astrazeneca
biogen
black diamond therapeutics
bladder cancer
blueprint medicines
bluerock therapeutics
boulder/denver blog main
boulder/denver top stories
cancer immunotherapy
cerovene
covid-19
crispr
david e. shaw
deals
deciphera pharmaceuticals
deerfield management
What
ipo
medicines
3
×
acquisitions
announced
bio
biotech
black
cancer
ceo
clinic
collabs
companies
company’s
course
covid
daniel
deal
development
diamond
discover
drug
eluded
experimental
gilead
gilead’s
growing
handiwork
help
helped
hopes
internal
introduce
landscape
lead
leading
lines
molecular
month
nears
new
Language
unset
Current search:
medicines
×
cancer
×
fda
×
" clinical trials "
×
@xconomy.com
4 years ago
Bio Roundup: Gilead’s $4.9B Deal, COVID-19 Collabs, IPO Plans & More
@xconomy.com
4 years ago
Schrödinger Sets Course for IPO to Support Growing Internal Pipeline
@xconomy.com
4 years ago
Black Diamond Lines Up IPO as Lead Cancer Drug Nears Clinic